Profile
Langdon L.
Miller is currently a Director at The Swedish Club and Dunn Gardens.
He previously worked as a Vice President-Clinical Research Oncology at Gilead Sciences, Inc., Chief Medical Officer at PTC Therapeutics, Inc., President & Chief Medical Officer at Cleveland BioLabs, Inc., Executive Vice President-Research & Development at Calistoga Pharmaceuticals, Inc., and Vice President-Global Clinical Research at Pharmacia Corp.
He also worked as a Principal at the National Cancer Institute and as a Chief Medical Officer & Executive Vice President at VelosBio, Inc. Dr. Miller holds a doctorate degree from Northwestern University.
Langdon L. Miller active positions
| Companies | Position | Start |
|---|---|---|
Dunn Gardens | Director/Board Member | 2012-12-31 |
The Swedish Club
The Swedish Club Property/Casualty InsuranceFinance Provides marine mutual insurance services | Director/Board Member | 2019-03-31 |
Former positions of Langdon L. Miller
| Companies | Position | End |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-03-31 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2012-12-31 |
Calistoga Pharmaceuticals, Inc.
Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Chief Tech/Sci/R&D Officer | 2010-12-31 |
| PTC THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2009-12-31 |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Chief Tech/Sci/R&D Officer | 2003-06-30 |
Training of Langdon L. Miller
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
PTC Therapeutics, Inc.
PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Cleveland BioLabs, Inc.
Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to activate the immune system and address serious medical needs | Health Technology |
Calistoga Pharmaceuticals, Inc.
Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Aura Biosciences, Inc.
Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
The Swedish Club
The Swedish Club Property/Casualty InsuranceFinance Provides marine mutual insurance services | Finance |
VelosBio, Inc.
VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research activities | Commercial Services |
Dunn Gardens | |
Oncternal Therapeutics, Inc.
Oncternal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that manufactures pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Langdon L. Miller
















